Please see full Prescribing Information for AREXVY. About SHINGRIX (Recombinant ZosterVaccine or RZV) SHINGRIX is a non-live, recombinant subunit vaccine indicated for the prevention of ...
About one in three people will develop shingles in their lifetime and nearly all adults aged 50 years and older carry the inactive virus that causes it. But the the risk of develo ...
The Advisory Committee on Immunization Practices (ACIP) recommends a single dose of zostervaccine for immunocompetent adults 60 years of age and older, based on the results of this study ...
Among the 461,323 individuals who received at least 1 RZV dose, 1264 experienced new-onset gout within 60 days postvaccination; 302 patients were determined to have incident cases of gout, with no ...